StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AGM/EGMApr 27, 2026, 05:36 PM

RVMD to Hold 2026 Annual Meeting on June 18

AI Summary

Revolution Medicines, Inc. (RVMD) filed its definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders. The meeting will be held online on June 18, 2026, at 7:30 a.m. Pacific Time. Stockholders will vote on the election of two Class III directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and an advisory vote on executive compensation.

Key Highlights

  • RVMD to hold 2026 Annual Meeting of Stockholders online on June 18, 2026, at 7:30 a.m. Pacific Time.
  • Stockholders will vote on the election of two Class III directors.
  • Stockholders will vote on the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026.
  • Stockholders will vote on a non-binding, advisory basis, on the compensation of named executive officers (Say-on-Pay).
  • Record Date for voting is April 23, 2026, with 212,592,561 shares outstanding.
  • Proxy materials were first made available on or about May 8, 2026.